Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EBIT Margin

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EBIT Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Margin(%) 14.135.497.707.20-2.11

What is the latest EBIT Margin ratio of SOTAC PHARMACEUTICALS ?

The latest EBIT Margin ratio of SOTAC PHARMACEUTICALS is 14.13 based on Mar2025 Consolidated results.
Year EBIT Margin
Mar202514.13
Mar20245.49
Mar20237.70
Mar20227.20
Mar2021-2.11

How is EBIT Margin of SOTAC PHARMACEUTICALS Trending?

Years EBIT Margin % Change
Mar2025 14.13
157.38
Mar2024 5.49
-28.70
Mar2023 7.7
6.94
Mar2022 7.2
Positive
Mar2021 -2.11 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EBIT Margin ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹137.0 Cr -11.6% -1.3% 7.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr -0.9% -1.4% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,044.0 Cr 2% 2.4% 11.2% Stock Analytics
CIPLA ₹121,574.0 Cr -0.8% -1.2% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -0.8% 1.7% -5.6% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-11.6%

-1.3%

7.9%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses